182 related articles for article (PubMed ID: 25915613)
1. Coumarins: Auspicious Cholinesterase and Monoamine Oxidase Inhibitors.
Orhan IE; Gulcan HO
Curr Top Med Chem; 2015; 15(17):1673-82. PubMed ID: 25915613
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents.
Yang J; Zhang P; Hu Y; Liu T; Sun J; Wang X
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):651-656. PubMed ID: 30746966
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
[TBL] [Abstract][Full Text] [Related]
5. Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2
Rullo M; Catto M; Carrieri A; de Candia M; Altomare CD; Pisani L
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835376
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
[TBL] [Abstract][Full Text] [Related]
7. Chemical library design, QSAR modeling and molecular dynamics simulations of naturally occurring coumarins as dual inhibitors of MAO-B and AChE.
Boulaamane Y; Kandpal P; Chandra A; Britel MR; Maurady A
J Biomol Struct Dyn; 2024; 42(4):1629-1646. PubMed ID: 37199265
[TBL] [Abstract][Full Text] [Related]
8. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase.
Brühlmann C; Ooms F; Carrupt PA; Testa B; Catto M; Leonetti F; Altomare C; Carotti A
J Med Chem; 2001 Sep; 44(19):3195-8. PubMed ID: 11543689
[TBL] [Abstract][Full Text] [Related]
9. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents.
Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A
J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.
Yun Y; Yang J; Miao Y; Wang X; Sun J
Bioorg Med Chem Lett; 2020 Feb; 30(4):126900. PubMed ID: 31882295
[TBL] [Abstract][Full Text] [Related]
11. Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
Xie SS; Wang X; Jiang N; Yu W; Wang KD; Lan JS; Li ZR; Kong LY
Eur J Med Chem; 2015 May; 95():153-65. PubMed ID: 25812965
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
14. Multi-targeted directed ligands for Alzheimer's disease: design of novel lead coumarin conjugates.
Repsold BP; Malan SF; Joubert J; Oliver DW
SAR QSAR Environ Res; 2018 Mar; 29(3):231-255. PubMed ID: 29390885
[TBL] [Abstract][Full Text] [Related]
15. Versatility of 7-Substituted Coumarin Molecules as Antimycobacterial Agents, Neuronal Enzyme Inhibitors and Neuroprotective Agents.
Kapp E; Visser H; Sampson SL; Malan SF; Streicher EM; Foka GB; Warner DF; Omoruyi SI; Enogieru AB; Ekpo OE; Zindo FT; Joubert J
Molecules; 2017 Sep; 22(10):. PubMed ID: 28973990
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.
Mzezewa SC; Omoruyi SI; Zondagh LS; Malan SF; Ekpo OE; Joubert J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1607-1621. PubMed ID: 34281458
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
18. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.
Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V
Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
